DNA Funded vs E8 Markets (2026) — Which Is Better?

At-a-Glance Match-Up

DNA Funded is an Australian prop firm backed by the ASIC-regulated DNA Markets broker, offering four challenge tracks with fixed 80% profit splits and raw spreads from 0.0 pips. E8 Markets is a US-based prop trading firm offering funded accounts up to $1M with configurable profit splits up to 100% and 24–48 hour payouts on simulated capital. The core difference: DNA Funded provides live market exposure with a fixed profit model, while E8 Markets offers higher profit potential and flexibility on simulated capital with no subscription fee.

Sticker Price vs Real Cost

DNA Funded charges $49 per month for access to all four challenge types, with one-time challenge fees (typically $297–$2,500 depending on account size) that are refunded upon your first profitable payout. E8 Markets operates on a free-to-evaluate model; there is no monthly subscription, but evaluation fees vary based on the account size and profit split configuration you choose at checkout. A standard evaluation might cost $350–$700, though the exact price scales with higher profit split percentages and larger account sizes. E8 Markets also offers a 14-day free trial with no credit card required, allowing traders to test the platform before committing to fees.

For traders planning to stay funded long-term, E8 Markets' no-subscription model becomes cheaper after just 3–4 months. However, DNA Funded's fee-refund policy effectively eliminates the challenge cost once you generate your first profitable payout, making the entry cost irrelevant for consistent traders. E8 Markets wins on initial cost transparency and trial availability; DNA Funded wins if you're confident you'll succeed and want to recover your entry fee.

The Toolkit

Capital & Market Exposure: E8 Markets funds up to $1M accounts, but all trading is on simulated capital with no live market execution. DNA Funded provides live market exposure through TradeLocker with 800+ CFD instruments, but account sizing depends on the challenge tier selected. For traders who value real-world market conditions and actual execution risk, DNA Funded is the technical winner. For traders prioritizing capital preservation while learning, E8 Markets' simulation eliminates real-loss risk.

Profit Splits & Flexibility: E8 Markets offers up to 100% profit splits, fully configurable at checkout—you can choose your own drawdown and profit-sharing ratio, paying more for higher splits. DNA Funded locks in 80% splits across all challenge types with no negotiation. E8 Markets wins decisively on flexibility and upside potential; traders who can maintain strict discipline can keep 100% of profits after their evaluation fee.

Payout Speed & Reliability: E8 Markets guarantees 24–48 hour payouts. DNA Funded does not publicly specify payout timelines, a critical omission for traders who trade for income. E8 Markets is faster and more transparent here. Given DNA Funded's relative newness (founded 2024), the lack of published payout data is a red flag compared to E8 Markets' clear guarantee.

Platform & Instrument Coverage: E8 Markets supports MT5, cTrader, MatchTrader, and TradeLocker—giving traders platform choice. DNA Funded uses TradeLocker exclusively with 800+ CFD instruments. E8 Markets' multi-platform flexibility is better for traders with platform preferences, but DNA Funded's 800+ CFD selection (including forex, indices, and commodities) exceeds what most competitors offer. DNA Funded excludes crypto from the Rapid challenge and offers no futures or options, a significant limitation for diversified traders.

Challenge Flexibility: DNA Funded offers four entry paths: 1-Phase (single test), 2-Phase (two-stage test), Rapid (accelerated), and Instant Funding (skip evaluation). E8 Markets has no minimum trading days required, allowing traders to pass evaluation in days. DNA Funded's no time-limit policy on 1-Phase and 2-Phase is generous, but E8 Markets' time flexibility (pass whenever you're ready) plus the 14-day free trial edge out DNA Funded for traders who want to test before committing capital.

Community & Transparency: Both platforms support API access and social features. DNA Funded's affiliate commission rates are not publicly disclosed, suggesting either non-competitive rates or lack of a structured affiliate program. E8 Markets does not publish this information either, so both are tied on transparency gaps.

Who Should Choose DNA Funded

- Live market traders who need real execution: If you want actual live CFD trading with real spreads, DNA Funded's TradeLocker integration and 0.0 pip raw spreads are non-negotiable advantages over simulated capital.
- Traders comfortable with a newer platform: DNA Funded's 2024 founding and ASIC broker backing make it credible for Australian and European traders, but it lacks E8 Markets' established operational track record. Choose this if you're willing to accept emerging-firm risk for ASIC regulatory credibility.
- CFD specialists with diverse instrument needs: If you trade 800+ instruments including forex, indices, commodities, and want no time pressure, DNA Funded's breadth and flexible timelines fit this profile.
- Traders planning long-term funded relationships: If you're confident in your consistency, DNA Funded's fee-refund-on-first-payout policy makes it a low-cost long-term choice compared to repeated E8 evaluation fees.

Who Should Choose E8 Markets

- Traders who want to preserve capital while proving themselves: E8 Markets' simulated capital means zero real-money loss risk during evaluation. If you're building a track record or testing a strategy, the $350–$700 evaluation fee is insurance, not a trading loss.
- High-profit-split seekers: If you can consistently profit and want to keep 80%, 90%, or 100% of gains, E8 Markets' configurable profit splits let you pay more for higher upside. DNA Funded's fixed 80% splits cap your earnings potential.
- Traders who need fast, transparent payouts: E8 Markets' guaranteed 24–48 hour payouts and no-subscription model appeal to traders who want predictable cash-out timelines. DNA Funded doesn't publish payout speed, a critical gap.
- Platform-flexible traders: If you already use MT5, cTrader, or MatchTrader and want to stick with your setup, E8 Markets' multi-platform support beats DNA Funded's TradeLocker-only requirement.

The Call

DNA Funded wins for traders who need live market exposure, require a regulated Australian broker, and trade CFDs long-term; its $49 monthly fee and fee refund on first payout make it the cheapest sustainable option for profitable traders. E8 Markets wins for traders prioritizing capital preservation, maximum profit splits (up to 100%), fast payouts (24–48 hours), and platform choice, with its free-to-try 14-day trial reducing entry risk. If you trade live markets daily and are confident, DNA Funded is the better value; if you want flexibility, high splits, and zero-risk evaluation, E8 Markets is the smarter choice.